The Anti-HBs Test detects antibodies against the surface antigen of the Hepatitis B virus, indicating immunity to Hepatitis B through past infection or vaccination.
This test is recommended to:
The Anti-HBs (Antibody to Hepatitis B Surface Antigen) Test measures the level of antibodies against the Hepatitis B surface antigen (HBsAg) in the blood. These antibodies are produced by the immune system after successful Hepatitis B vaccination or recovery from a previous Hepatitis B infection. Their presence generally indicates protective immunity against the Hepatitis B virus (HBV).
Healthcare providers commonly recommend this test to determine whether an individual is protected against Hepatitis B, especially after completing the Hepatitis B vaccination series. It is also used to assess immunity in healthcare workers, laboratory personnel, pregnant women, dialysis patients, organ transplant recipients, and individuals at increased risk of HBV exposure.
Furthermore, the Anti-HBs Test helps verify vaccine effectiveness, determine the need for a booster dose in high-risk individuals, and differentiate immunity from active infection when interpreted with other Hepatitis B markers. It is often performed alongside HBsAg, Anti-HBc Total, Anti-HBc IgM, and other Hepatitis B tests to provide a comprehensive evaluation of Hepatitis B infection and immune status.
The Anti-HBs Test measures antibodies against the Hepatitis B surface antigen to determine whether you have protective immunity against Hepatitis B from vaccination or a previous infection.
No. Fasting is generally not required for this blood test. However, always follow any specific instructions provided by your healthcare provider before sample collection.
A positive Anti-HBs result usually indicates that you have protective immunity against Hepatitis B due to successful vaccination or recovery from a previous infection. Your healthcare provider may interpret the result along with HBsAg and Anti-HBc test results to determine your complete Hepatitis B status.